Evaluation of antithymocyte globulin pharmacokinetics and pharmacodynamics in children
- 1 January 2016
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 137 (1) , 306-309.e4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Population Pharmacokinetic Modeling of Thymoglobulin® in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized DosingClinical Pharmacokinetics, 2014
- Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcomeBlood, 2014
- Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysisCritical Reviews in Oncology/Hematology, 2013
- IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHDBone Marrow Transplantation, 2011
- Total and Active Rabbit Antithymocyte Globulin (rATG;Thymoglobulin®) Pharmacokinetics in Pediatric Patients Undergoing Unrelated Donor Bone Marrow TransplantationTransplantation and Cellular Therapy, 2009
- Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for RComputer Methods and Programs in Biomedicine, 2008
- Maximum likelihood estimation in nonlinear mixed effects modelsComputational Statistics & Data Analysis, 2005
- Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulinBone Marrow Transplantation, 2001
- The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemiaBone Marrow Transplantation, 2000
- Induction of Fas (Apo-1, CD95)-Mediated Apoptosis of Activated Lymphocytes by Polyclonal Antithymocyte GlobulinsBlood, 1998